REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 149 filers reported holding REPLIMUNE GROUP INC in Q2 2024. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $64,926 | -32.7% | 7,214 | -38.9% | 0.01% | -25.0% |
| Q1 2024 | $96,471 | +67.5% | 11,808 | +72.8% | 0.01% | +9.1% |
| Q4 2023 | $57,602 | +123.1% | 6,833 | +352.8% | 0.01% | +57.1% |
| Q3 2023 | $25,819 | +46.9% | 1,509 | +99.3% | 0.01% | +40.0% |
| Q2 2023 | $17,578 | +29.6% | 757 | -1.4% | 0.01% | 0.0% |
| Q1 2023 | $13,563 | -1.3% | 768 | +52.1% | 0.01% | -16.7% |
| Q4 2022 | $13,736 | +71.7% | 505 | +9.3% | 0.01% | +100.0% |
| Q3 2022 | $8,000 | – | 462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $41,619,000 | 21.14% |
| Omega Fund Management, LLC | 5,103,455 | $74,567,000 | 19.02% |
| Foresite Capital Management IV, LLC | 1,228,656 | $18,012,000 | 5.09% |
| Foresite Capital Management III, LLC | 779,656 | $11,430,000 | 3.75% |
| BVF INC/IL | 1,724,609 | $25,283,000 | 2.76% |
| Redmile Group, LLC | 2,197,003 | $32,208,000 | 0.91% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 711,770 | $10,435,000 | 0.41% |
| EMERALD ADVISERS, LLC | 693,178 | $10,162,000 | 0.41% |
| Artal Group S.A. | 600,000 | $8,796,000 | 0.36% |
| Polar Capital LLP | 175,000 | $2,566,000 | 0.02% |